Acute Porphyria Drugs

C09BA06 - Quinapril and Diuretics

Probably not porphyrinogenic
PNP

Rationale
Quinapril: No evidence of CYP-dependent metabolism. Hydrochlorthiazide: Not metabolised. Probably no CYP-affinity. Clinical experience of non-porphyrinogenicity. Conflicting evidence.
Chemical description
Quinapril: HCl-salt of quinapril, which is a prodrug of the metabolite quinaprilate is excreted unchanged by the kidneys. Hydrochlorthiazide: thiazide diuretic, sulfonamide congener. Eliminated in urine in unchanged form. Probably no CYP-affinity.
Personal communication
Hydrochlorthiazide: Thunell, patient report (n=1): tolerated. Andersson, patient reports (n=10): tolerated.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes C09B / C09BA or go back.
References
# Citation details PubMed ID
Porphyria Drug Lists
1. Australian List
Australian Porphyria Association No longer maintained
2. French List
Centre Français des Porphyries
3. EPI List
European Porphyria Initiative No longer maintained
4. South African List
Porphyria South Africa No longer maintained
Tradenames

Quinapril/HCT Acuilix · Quinapril Hctz Bicetil · Lidaltrin · Quinapril / Hidroclorotiazida Accuretic · Quinapril e Idroclorotiazide · Quinapril Idroclorotiazide · Quinazide Accuzide · Accuzide Forte · Accuzide Forte Plus Accuretic · Quinapril Accupro · Quinaplus · Quinapril / Hydrochlorothiazid Accuretic Quinapril Hctz · Quinapril/Hctz Accuzide · Curapril · Quinaplus · Quinapril / Hydrochlorothiazide · Quinapril HCT · Quinapril/HCT Kinapril / hidroklorotiazid
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙